Table 6.
Cost of illness for morbidity assessment
| Cities | Morbidity illness | Cost of illness as reported (year) | Cost of illness USD (2019) | Author (year) |
|---|---|---|---|---|
| Delhi | COPD | INR 44390 (2005) | 1675 | Koul et al. (2019) |
| Asthma | USD 637 (2019) | 637 | Ghoshal et al. (2016) | |
| Respiratory disease | USD 637 (2019) | 637 | Ghoshal et al. (2016) | |
| Cardiovascular disease | INR 300000 (2018) | 4522 | Apoorva (2018) | |
| London | COPD | GBP 1640 (2006) | 3028 | Starkie et al. (2008) |
| Asthma | Euro 169 (2010) | 240 | Mukherjee et al. (2016) | |
| Respiratory disease | GBP 1850 (2014) | 2603 | Burki (2017) | |
| Cardiovascular disease | GBP 7600 (2015) | 10,492 | Bhatnagar et al. (2016) | |
| Paris | COPD | Euro 7924 (2015) | 9174 | Bourbeau et al. (2019) |
| Asthma | Euro 538 (2010) | 663 | Doz et al. (2013) | |
| Respiratory disease | GBP 1850 (2014) | 2603 | Burki (2017) | |
| Cardiovascular disease | Euro 4719 (2013) | 5541 | Tuppin et al. (2016) | |
| Wuhan | COPD | USD 4527 (2019) | 4527 | (Koul et al. 2019, Li et al. 2018) |
| Asthma | USD 1590 (2015) | 1721 | (Shan 2017) | |
| Respiratory disease | USD 1089 (2016) | 1133 | (Li et al. 2018) | |
| Cardiovascular disease | USD 2236 (2012) | 2581 | (Wang et al. 2015) |